Engineered CD19-CAR NK cells as an off-the-shelf alternative to B cell leukemia and lymphoma treatment (2020)
- Authors:
- USP affiliated authors: FARIAS, KELEN CRISTINA RIBEIRO MALMEGRIM DE - FCFRP ; ANTONIETTO, KAMILLA SWIECH - FCFRP ; COVAS, DIMAS TADEU - FMRP ; CASTRO, VIRGÍNIA PICANÇO E - FMRP ; SILVESTRE, RENATA NACASAKI - FMRP
- Unidades: FCFRP; FMRP
- DOI: 10.1016/j.htct.2020.10.703
- Subjects: LEUCEMIA; LINFOMA; LINFÓCITOS B; LINFÓCITOS T
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Hematology, Transfusion and Cell Therapy
- ISSN: 2531-1379
- Volume/Número/Paginação/Ano: v. 42, supl. 2, res. 701, p. S418, 2020
- Conference titles: Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular (HemoPlay 2020)
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
SILVESTRE, Renata Nacasaki et al. Engineered CD19-CAR NK cells as an off-the-shelf alternative to B cell leukemia and lymphoma treatment. Hematology, Transfusion and Cell Therapy. São Paulo: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.htct.2020.10.703. Acesso em: 21 jan. 2026. , 2020 -
APA
Silvestre, R. N., Eitler, J., Fantacini, D. M. C., Farias, K. C. R. M. de, Swiech, K., Covas, D. T., et al. (2020). Engineered CD19-CAR NK cells as an off-the-shelf alternative to B cell leukemia and lymphoma treatment. Hematology, Transfusion and Cell Therapy. São Paulo: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.htct.2020.10.703 -
NLM
Silvestre RN, Eitler J, Fantacini DMC, Farias KCRM de, Swiech K, Covas DT, Tonn T, Picanço-Castro V. Engineered CD19-CAR NK cells as an off-the-shelf alternative to B cell leukemia and lymphoma treatment [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S418.[citado 2026 jan. 21 ] Available from: https://doi.org/10.1016/j.htct.2020.10.703 -
Vancouver
Silvestre RN, Eitler J, Fantacini DMC, Farias KCRM de, Swiech K, Covas DT, Tonn T, Picanço-Castro V. Engineered CD19-CAR NK cells as an off-the-shelf alternative to B cell leukemia and lymphoma treatment [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S418.[citado 2026 jan. 21 ] Available from: https://doi.org/10.1016/j.htct.2020.10.703 - Chimeric antigen receptor T Cell: development and production
- Chimeric antigen receptor T Cells: development and production
- Immunotherapy is a treatment that boosts the body’s natural defenses to fight cancer. [Prefácio]
- Non-viral engineering of CAR-NK cells for cancer immunotherapy
- Emerging CAR T cell therapies: clinical landscape and patent technological routes
- CAR-T cells for cancer treatment: current design and next frontiers
- Optimizing intracellular signaling domains for CAR-NK cells
- Determination of cytotoxic potential of CAR-T cells in co-cultivation assays
- Establishment of a simple and efficient platform for car-t cell generation and expansion: from lentiviral production to in vivo studies
- A Fully-closed and automated hollow fiber bioreactor for clinical-grade manufacturing of human Mesenchymal stem/stromal cells
Informações sobre o DOI: 10.1016/j.htct.2020.10.703 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003033142.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
